Menu
Recruiting NCT06750120

Addressing the Double Burden of Malnutrition in Guatemala

No phase Interventional Maternal Obesity Complicating Pregnancy, Birth,or Puerperium Child Malnutrition

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Family food ration, Optimal weight counseling, Enhanced Usual Care.
Who it may be relevant to
Registry conditions: Maternal Obesity Complicating Pregnancy, Birth,or Puerperium, Child Malnutrition. Basic parameters: from 16 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Guatemala
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

An Integrated Intervention to Address the Double Burden of Malnutrition in Guatemala

Overview

Globally, populations are experiencing increases in the double burden of malnutrition, commonly defined as maternal overweight/obesity and child stunting in the same household. This study will evaluate an integrated intervention combining food supplementation for pregnant and postpartum women and their infants with behavioral counseling to promote healthy maternal weight, nutrition, physical activity, and infant feeding practices. The goal is to reduce the double burden of malnutrition in rural Indigenous communities in Guatemala.

Detailed description

K'ASLEM (meaning "life" in the Kaqchikel Mayan language) is an individually randomized, parallel-group Hybrid Type 1 effectiveness-implementation clinical trial conducted in Indigenous Maya communities in Guatemala that have among the world's highest levels of double burden of malnutrition. The trial will enroll 766 pregnant women aged 16 years or older before 28 weeks gestation with 1:1 allocation to intervention and comparator arms. The intervention arm will receive two integrated interventions: (a) food supplementation for pregnant and postpartum women and for infants and (b) behavioral counseling to optimize maternal weight and promote healthy nutrition, physical activity, and infant feeding practices. The comparator is enhanced usual care, which includes routine government prenatal and postnatal services along with care navigation and provision of fortified flour for infants. Mother-child dyads will be followed until 12 months after birth. Co-primary outcomes are maternal weight and child length-for-age at 12 months after birth. Complementing these trial outcomes, the study will collect mixed-methods data on implementation outcomes and apply implementation mapping to develop strategies for future scale-up. The trial will also include an economic evaluation to inform policymakers of costs and cost-effectiveness. A major feature of the trial is a focus on pragmatism and fairness, working to enroll vulnerable families from rural Guatemala who stand most to benefit from the intervention but who are commonly excluded from clinical trials.

Interventions

  • Dietary supplement Family food ration
    Monthly household food rations containing 5 food groups (eggs, fortified blended flour, oil, legumes, and fresh fruits and vegetables), providing approximately 150 kcal per capita per day assuming a median household of 5.
  • Behavioral Optimal weight counseling
    Individually tailored monthly home visits by trained educators addressing healthy gestational weight gain, postpartum weight management, maternal nutrition, physical activity, and infant feeding practices.
  • Other Enhanced Usual Care
    Usual care: Free pregnancy, postnatal, and infant care through the Ministry of Health services, including vitamin supplementation, infant vaccinations, and growth monitoring. Enhancements: Care navigation for high-risk or emergency conditions and ensuring infants aged 6 to 12 months receive government-recommended fortified blended flour.

Primary outcome measures

  • Child length-for-age z score [Time frame: 12 months of age]
  • Maternal weight [Time frame: 12 months postpartum]
Secondary outcome measures (4)
  • Child stunting [Time frame: 12 months of age]
  • Child global development score [Time frame: 12 months of age]
  • Maternal overweight/obesity [Time frame: 12 months postpartum]
  • Maternal hemoglobin [Time frame: 12 months postpartum]

Eligibility criteria

Inclusion criteria

  • Pregnant women aged 16 years or older
  • Gestational age less than 28 weeks

Exclusion criteria

  • History of pregestational diabetes (type 1 or type 2), history of gestational diabetes in a previous pregnancy, or diagnosis of gestational diabetes in the current pregnancy
  • Multifetal gestation (twins or higher-order pregnancies)
  • Currently participating in another research study involving an intervention
  • Has a family member who has already been invited to participate in this study and/or shares a kitchen with such a person
  • Has a serious underlying medical or psychiatric condition requiring specialized clinical care, including active cancer, severe renal or hepatic disease, symptomatic heart disease, autoimmune disorders requiring immunosuppressive therapy, active thromboembolism or coagulopathy, or severe mental health condition, or other conditions at the discretion of the investigators
  • Plans to move out of the study area within the next two years

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Guatemala · 1 center
  • Community recruitment — Tecpán Guatemala

Publications

  • Popkin BM, Corvalan C, Grummer-Strawn LM. Dynamics of the double burden of malnutrition and the changing nutrition reality. Lancet. 2020 Jan 4;395(10217):65-74. doi: 10.1016/S0140-6736(19)32497-3. Epub 2019 Dec 15. PMID 31852602

Identifiers

NCT: NCT06750120 · 2024P003339

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗